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Objective: This study examined the characteristics and correlates of
past 12-month simultaneous sedative-alcohol use (SSAU) in a
community sample (N=167) reporting non-medical use of sedatives.
Sample: For the present analysis, 167 participants who reported non-
medical sedative use for more than 5 days in the past 12 months, and
use of alcohol in the past 12 months, were included.
Findings: SSAU was more prevalent among 18 to 25 year olds (75%),
than 26-49 (63%), and 50-65 year age groups (52%); and among men,
relative to women (74% versus 51%). SSAU was also higher among those
reporting past 12-month cannabis use (versus no cannabis use) (73%
versus 51%), and cocaine use (versus no cocaine use) (79% versus 52%).
Furthermore, participants who reported sedative use for motives such as
‘to get high, experiment, change mood, relieve stress, party, and ‘just
because,’ were more likely to report past 12-month SSAU (chisquare;
p<0.05) than their counterparts. Multivariate logistic regression
analyses indicated that being male (adjusted OR=2.21, 95% CI=1.06-
4.60), Caucasian (adjusted OR=2.37, 95% CI=1.09-5.18), having a
history of past 12-month cocaine use (adjusted OR=2.27, 95% CI=1.01-
5.06), and reporting higher number of motives for sedative use
(adjusted OR=4.13, 95% CI=1.71-9.97), were significantly associated
with past 12-month SSAU.
Conclusion: Findings underscore the need for considering differential
risk factors in tailoring preventive interventions for reducing SSAU
among sedative non-medical users.
Data were collected as part of the ongoing NIDA-funded Prescription
Drug Misuse, Abuse, and Dependence study in St. Louis.
Eligibility criteria: Non-medical sedative use for more than 5 days in
the past 12 months, and use of alcohol in the past 12 months.
Measures: All information for the present analysis was obtained from
the Washington University Risk Behavior Assessment (WU-RBA).
Non-medical sedative use: Use of muscle relaxants, sleeping pills, or
other sedatives in the last 365 days, (a) in ways other than prescribed, (b)
when not prescribed.
SSAU: Use of sedatives and alcohol together, in the last 12 months.
Motives for sedative use in the past 12 months: Fifteen motives for
sedative use were assessed using the WU-RBA (Table 1). Additionally,
responses on these items (Yes/No) were summed to create a Motives
Index (scores 0-15), representing the number of motives endorsed by the
participants. Higher scores on Motives Index indicate more motives for
sedative use in the past 12 months.
Mean age (N=167) was 37 years (SD=13), 58% was male, 49% Caucasian, and 73% had <
high-school education. Past 12-month cannabis use was reported by 63%, cocaine use by
47%, and heroin/opium use by 26%. Past 12-month SSAU was reported by 65 percent.
For majority (80%), benzodiazepines were the preferred sedative of choice. Among
benzodiazepine users, alprazolam was the most frequently reported (62%).
 Past 12-month SSAU appeared to be more prevalent among younger adults, men, and among
those reporting past 12-month cannabis and cocaine use. Furthermore, participants who reported
sedative use for motives such as to get high, experiment, to change mood/be happy, relieve stress,
to party, and ‘just because,’ were more likely to report past 12-month SSAU.
 Multivariate logistic regression analyses indicated that being male, Caucasian, reporting past
12-month cocaine use, and having higher number of motives for sedative use, were significantly
associated with past 12-month SSAU.
 Findings underscore the need for considering differential risk factors in tailoring preventive
interventions for reducing SSAU among sedative non-medical users. They also highlight the need
for raising awareness about the risks involved when sedatives are used for non-medical purposes,
which increases the possibility of drug interactions, and to consider such factors as age, gender,
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Unadjusted OR Adjusted OR
OR 95% CI aOR 95% CI
Agea 1.36 1.06 - 1.76 0.76 0.56 – 1.04
Male 2.72 1.41 - 5.22 2.21 1.06 – 4.60
Caucasianb 2.34 1.22 – 4.52 2.37 1.09 – 5.18
Past 12-month
cannabis use
2.56 1.32 - 4.96 1.42 0.64 – 3.12
Past 12-month 
cocaine use
3.62 1.81 - 7.21 2.27 1.01 – 5.06
Motives Indexa 4.60 2.09 - 10.14 4.13 1.71 – 9.97
aContinuous variables; for Motives Index, aOR indicates significant increase in risk when the number of
motives increase by 5;
bNon-Caucasian as referent group; OR: Odds Ratio; aOR: adjusted Odds Ratio; 95% CI: 95% 
Confidence Interval
RESULTS
Table 1. Sedative Non-medical Users who reported, vs. did not 
report,  Past 12-month SSAU, by Selected Variables (N=167)
SSAU (n=108) No SSAU (n=59) p-value
Age
18-25 years 39 % 24 %
26-49 years 42 % 44 % 0.02*
50-65 years 19 % 32 %
Gender
Male 67 % 42 % 0.002*
Female 33 % 58 %
Education
Less than high-school 75 % 69 % 0.44
Above high school 25 % 31 %
Ethnicity
Caucasian 56 % 36 % 0.009*
Non-Caucasian 44 % 64 %
Past 12-month illicit drug use
Cannabis 71 % 49 % 0.004*
Cocaine 57 % 27 % <0.0002*
Heroin 27 % 25 % 0.84
Motives for sedative use
To get high 71  % 42 % 0.0003*
To experiment 36 % 19 % 0.02*
Peer pressure 5 % 7 % 0.56
To function 37 % 44 % 0.39
Alter other prescription drugs 
effects
31 % 24 % 0.33
To change mood / be happy 75 % 42 % <0.0001*
To stay awake 7 % 5 % 0.55
To study / concentrate 8 % 7 % 0.70
To increase energy 12 % 14 % 0.79
To relieve stress 91 % 80 % 0.04*
For pain 33 % 20 % 0.09
*Statistically significant; p≤0.05 (Chi-square/Fisher/t-test)
†Number of motives endorsed; mean Motives Index score: 5.36 (SD 2.46)
Table 2. Univariate & Multivariate Logistic Regression Predicting 
Past 12-month SSAU(n=167)
Table 1.. continued
SSAU (n=108) No SSAU (n=59) p-value
To sleep 73 % 69 % 0.64
Just because 65 % 39 % 0.001*
To party 49 % 20 % 0.0003*
To lose weight 0 3 % 0.06
Motives Index (mean, SD) 5.92 (2.22) 4.35 (2.55) 0.0001*
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